Reductive metabolism and DNA binding of misonidazole
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 101 (1) , 47-54
- https://doi.org/10.1016/0041-008x(89)90210-x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Regioselective formation of a misonidazole-glutathione conjugate as a function of pH during chemical reductionBiochemical Pharmacology, 1988
- Xanthine oxidase-catalyzed dna binding of dihydrodiol derivatives of nitro-polycyclic aromatic hydrocarbonsBiochemical and Biophysical Research Communications, 1986
- DNA damage induced by reductively activated nitroimidazoles—pH effectsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Oxidative microsomal metabolism of 1-nitropyrene and DNA-binding of oxidized metabolites following nitroreductionCarcinogenesis: Integrative Cancer Research, 1986
- Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancerBiochemical Pharmacology, 1986
- Formation and persistence of arylamine DNA adducts in vivo.Environmental Health Perspectives, 1985
- 1-nitrosopyrene: An intermediate in the metabolic activation of 1-nitropyrene to a mutagen in Salmonella typhimurium TA1538☆Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1985
- Xanthine oxidase catalyzed binding of 1-nitropyrene to DNABiochemical and Biophysical Research Communications, 1982
- Reduction of misonidazole and its derivatives by xanthine oxidaseBiochemical Pharmacology, 1981
- In vitro reaction of the carcinogen, N-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenineCarcinogenesis: Integrative Cancer Research, 1980